Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Daryl Osbahr

Orthopaedic Surgery Winter Park, FL Medical Doctor

NPI 1699944017 CMS profile 121807

255 N Lakemont Ave Ste 207, Winter Park, FL 32792

Open in the dashboard

General payments

$558,920

345 records reported · program years 2019–2025

Research payments

$43,281

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$60 paid to institutions, not to them · program year 2019

Through program year 2025, Daryl Osbahr of Winter Park, FL is reported in the CMS Open Payments database as having received $558,920 across 345 general payments and $43,281 in research payments paid to them. Separately, studies naming them as principal investigator received $60 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $162,425 68
2024 General $101,015 53
2023 General $39,318 17
2022 General $17,323 20
2021 General $45,939 49
2020 General $42,594 37
2019 General $150,305 101
2019 Research $43,281 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daryl Osbahr
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Daryl Osbahr were reported at $162,425. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Daryl Osbahr Orthopaedic Surgery median Middle half National median
2019 $150,305 $644 $140–$2,844 $163
2020 $42,594 $312 $75–$1,860 $114
2021 $45,939 $520 $117–$2,495 $132
2022 $17,323 $598 $128–$2,731 $149
2023 $39,318 $461 $128–$2,264 $160
2024 $101,015 $497 $134–$2,475 $164
2025 $162,425 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $463,902 296 payments
  2. Miach Orthopaedics, Inc. $87,827 12 payments
  3. Fones Marketing Management, Inc. $5,296 17 payments
  4. RTI Surgical, Inc $1,250 1 payment
  5. Smith+Nephew, Inc. $208 7 payments
  6. Stryker Corporation $158 2 payments
  7. Vericel Corporation $155 3 payments
  8. Molnlycke Health Care US, LLC $25 1 payment
  9. Pacira Pharmaceuticals Incorporated $24 1 payment
  10. Dynasplint Systems Inc. $24 2 payments
  11. Other $51 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $396,714 49 payments
  2. Consulting Fee $125,530 14 payments
  3. Travel and Lodging $26,564 82 payments
  4. Food and Beverage $6,869 197 payments
  5. Education $3,242 3 payments
Products named General payments · program years 2019–2025
  1. Pre-Sutured Tendon $1,250 1 payment
  2. MACI $155 3 payments
  3. SALVATION $138 1 payment
  4. Bone Anchors with Arthroscopic Delivery System $103 3 payments
  5. FIRSTPASS $54 1 payment
  6. SHOULDER IMPLANTS SPEEDBRIDGE COMPOSITE ANCHORS $39 1 payment
  7. Mepilex Border Post-Op Ag $25 1 payment
  8. Exparel $24 1 payment
  9. Dynasplint $24 2 payments
  10. Q-FIX $21 1 payment
  11. Other $162 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Arthrex, Inc. $43,281 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

62

Median for Sports Medicine: 144

Drug cost

$253

Median for Sports Medicine: $1,027

Branded share of claims

0%

Median for Sports Medicine: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 26 $142
Meloxicam Generic 36 $110

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,691 Part D prescribers listed as Sports Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 32 billing codes

Paid by Medicare

$28,506

Of which drugs: $1,419

Medicare patients

61

Average age 69

Services billed

598

29 women, 32 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 67%
Ischemic heart disease 30%
Diabetes 23%
Chronic kidney disease 20%
Alzheimer's or dementia 0%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 19 160 $118

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

347 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record